Tris Pharma Announces Acceptance of New Publication Highlighting Promise of Dual NOP-MOP (dual-NMR) Agonists for the Treatment of Moderate-to-Severe Pain

Preferential MOP agonists such as oxycodone are often required for effective management of moderate to severe pain but come with significant ...